HROW
Harrow Health, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$38.54
+0.73%Margins
Gross margin
73.3%
EBITDA margin
1.6%
EBIT margin
2.1%
Net margin
-13.5%
FCF margin
2.1%
-244.9%
Return on equity
-8.9%
Return on assets
1.8%
Return on invested capital
0.66x
Asset turnover
$6.3M
Cash from operations
$2.24
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026